Skip to main content
Year archive

Affluent Medical — 2025 filings

All 57 regulatory filings released by Affluent Medical (AFME) in 2025, sourced directly from the official regulator.

57 Filings
2025 Period
2025 filings (57)
Filing Released Lang
Affluent Medical announces upcoming acquisition of Caranx Medical and Artedrone, becoming Carvolix, pioneering cardiovascular therapies.
M&A Activity
2025-12-19 English
Affluent Medical annonce l’acquisition prochaine de Caranx Medical et Artedrone et devient Carvolix, pionnier des thérapies cardiovasculaires.
M&A Activity
2025-12-19 French
Affluent Medical announces upcoming acquisition of Caranx Medical and Artedrone, becoming Carvolix, pioneering cardiovascular therapies.
M&A Activity
2025-12-19 English
Affluent Medical : Nombre d’actions composant le capital social et nombre total de droits de vote au 30.09.25.
Share Issue/Capital Change
2025-11-05 French
Affluent Medical : Nombre d’actions composant le capital social et nombre total de droits de vote au 31.10.25.
Declaration of Voting Results & Voting Rights Announcements
2025-11-05 French
Affluent Medical : Nombre dactions composant le capital social et nombre total de droits de vote au 30.09.25.
Declaration of Voting Results & Voting Rights Announcements
2025-11-05 French
Affluent Medical : Des résultats prometteurs pour la valve mitrale biomimétique Epygon présentés au congrès de cardiologie TCT aux Etats-Unis.
Regulatory Filings
2025-10-30 French
Affluent Medical : Promising results for the Epygon biomimetic mitral valve presented at the TCT cardiology congress in the United States.
Regulatory Filings
2025-10-30 English
Affluent Medical : Promising results for the Epygon biomimetic mitral valve presented at the TCT cardiology congress in the United States.
Regulatory Filings
2025-10-30 English
Affluent Medical : Nombre d’actions composant le capital social et nombre total de droits de vote
Share Issue/Capital Change
2025-10-03 French
Affluent Medical : Nombre dactions composant le capital social et nombre total de droits de vote
Declaration of Voting Results & Voting Rights Announcements
2025-10-03 French
Affluent Medical : Rapport financier semestriel
Interim / Quarterly Report H1 2025
2025-10-02 French
Affluent Medical : RESULTATS SEMESTRIELS 2025 : Affluent Medical franchit de nouvelles étapes majeures et structurantes au 1er semestre 2025
Interim / Quarterly Report H1 2025
2025-09-30 French
Affluent Medical: H1 2025 RESULTS: Affluent Medical took major new and transformative steps during the first half of 2025
Interim / Quarterly Report H1 2025
2025-09-30 English
Affluent Medical: H1 2025 RESULTS: Affluent Medical took major new and transformative steps during the first half of 2025
Earnings Release H1 2025
2025-09-30 English
Affluent Medical : Affluent Medical announces that the clinical results of the Artus robotic urinary sphincter were presented at the international conferences of the UAA and the ICS
Regulatory Filings
2025-09-29 English
Affluent Medical : Affluent Medical annonce la présentation des résultats cliniques du sphincter urinaire robotique Artus, aux congrès internationaux de l’UAA et de l’ICS
Regulatory Filings
2025-09-29 French
Affluent Medical : Affluent Medical announces that the clinical results of the Artus robotic urinary sphincter were presented at the international conferences of the UAA and the ICS
Regulatory Filings
2025-09-29 English
Affluent Medical : Bilan semestriel du contrat de liquidité contracté avec la banque Rothschild Martin Maurel
Transaction in Own Shares
2025-07-08 French
Affluent Medical : Bilan semestriel du contrat de liquidite contracte avec la banque Rothschild Martin Maurel
Regulatory Filings
2025-07-08 French
Affluent Medical : Affluent Medical met en lumière les avancées cliniques et réglementaires de son dispositif médical innovant Artus dans une interview exclusive sur Boursorama
Regulatory Filings
2025-07-01 French
Affluent Medical : Affluent Medical met en lumiere les avancees cliniques et reglementaires de son dispositif medical innovant Artus dans une interview exclusive sur Boursorama
Regulatory Filings
2025-07-01 French
Affluent Medical : Nombre d’actions composant le capital social et nombre total de droits de vote
Declaration of Voting Results & Voting Rights Announcements
2025-06-25 French
Affluent Medical : Nombre dactions composant le capital social et nombre total de droits de vote
Declaration of Voting Results & Voting Rights Announcements
2025-06-25 French
Affluent Medical : Affluent Medical extends the horizon of its cash position to end-2025 with support from its key shareholders
Capital/Financing Update
2025-06-24 English
Affluent Medical :Affluent Medical étend son horizon de trésorerie à fin 2025 avec le soutien de ses principaux actionnaires
Capital/Financing Update
2025-06-24 French
Affluent Medical : Affluent Medical extends the horizon of its cash position to end-2025 with support from its key shareholders
Capital/Financing Update
2025-06-24 English
Affluent Medical : Assemblée Générale Ordinaire Annuelle et Extraordinaire du 19 juin 2025
AGM Information
2025-05-28 French
Affluent Medical announces promising performance results for its Artus artificial urinary sphincter and receives approval to initiate pivotal phase of its clinical trial .
Regulatory Filings
2025-05-15 English
Affluent Medical annonce des résultats prometteurs pour son sphincter urinaire artificiel Artus et obtient l’autorisation de lancer la phase pivot de son essai clinique.
Regulatory Filings
2025-05-15 French
Affluent Medical announces promising performance results for its Artus artificial urinary sphincter and receives approval to initiate pivotal phase of its clinical trial
Regulatory Filings
2025-05-15 English
Affluent Medical : Nombre d’actions composant le capital social et nombre total de droits de vote au 30.04.25
Declaration of Voting Results & Voting Rights Announcements
2025-05-15 French
Affluent Medical : Mise à disposition du Document d’Enregistrement Universel (DEU) 2024.
Report Publication Announcement
2025-05-02 French
Affluent Medical : Document d'Enregistrement Universel 2024 incluant le rapport financier annuel.
Annual Report
2025-05-02 French
Document d'enregistrement universel 2024
Annual Report (ESEF) FY 2024
2025-04-30 French
Affluent Medical : 2024 FULL YEAR RESULTS Affluent Medical reached major new milestones in executing its clinical roadmap
Earnings Release FY 2024
2025-04-24 English
Affluent Medical : RESULTATS ANNUELS 2024 : Affluent Medical franchit de nouveaux jalons clés dans l’exécution de sa feuille de route clinique
Earnings Release FY 2024
2025-04-24 French
2024 FULL YEAR RESULTS Affluent Medical reached major new milestones in executing its clinical roadmap
Earnings Release FY 2024
2025-04-24 English
Affluent Medical Announces Progress Toward European Clinical Study of Artificial Sphincter Artus for the Treatment of Urinary Stress Incontinence in Women.
Environmental & Social Information
2025-04-15 English
Affluent Medical progresse vers une étude clinique européenne sur le sphincter artificiel Artus pour le traitement de l'incontinence urinaire d'effort chez la femme.
Regulatory Filings
2025-04-15 French
Affluent Medical Announces Progress Toward European Clinical Study of Artificial Sphincter Artus for the Treatment of Urinary Stress Incontinence in Women
Regulatory Filings
2025-04-15 English
Affluent Medical : Nombre d’actions composant le capital social et nombre total de droits de vote au 31.03.25
Declaration of Voting Results & Voting Rights Announcements
2025-04-11 French
Affluent Medical announces several key appointments for Medical and Clinical affairs.
Board/Management Information
2025-03-12 English
Affluent Medical announces several key appointments for Medical and Clinical affairs.
Board/Management Information
2025-03-11 English
Affluent Medical annonce plusieurs nominations clés aux affaires médicales et cliniques.
Board/Management Information
2025-03-11 French
Affluent Medical announces several key appointments for Medical and Clinical affairs.
Board/Management Information
2025-03-11 English
Affluent Medical : Nombre d’actions composant le capital social et nombre total de droits de vote au 28.02.25
Declaration of Voting Results & Voting Rights Announcements
2025-03-06 French
Affluent Medical appoints Liane Teplitsky - a senior executive in the medical device industry as a new member of the Board of Directors
Board/Management Information
2025-02-26 English
Affluent Medical appoints Liane Teplitsky - a senior executive in the medical device industry as a new member of the Board of Directors.
Board/Management Information
2025-02-25 English
Affluent Medical nomme Liane Teplitsky à son Conseil d’administration, une experte reconnue dans le secteur des dispositifs médicaux.
Board/Management Information
2025-02-25 French
Affluent Medical appoints Liane Teplitsky - a senior executive in the medical device industry as a new member of the Board of Directors
Board/Management Information
2025-02-25 English
Affluent Medical : Nombre d’actions composant le capital social et nombre total de droits de vote au 31.01.25.
Regulatory Filings
2025-02-13 French
Affluent Medical annonce le succès de la 10e implantation chez l’homme de son sphincter urinaire Artus marquant la finalisation de la phase pilote.
Regulatory Filings
2025-01-30 French
Affluent Medical announces 10th successful human implantation of its Artus urinary sphincter, marking completion of the pilot phase.
Regulatory Filings
2025-01-30 English
Affluent Medical announces 10th successful human implantation of its Artus urinary sphincter, marking completion of the pilot phase
Legal Proceedings Report
2025-01-30 English
Affluent Medical : Bilan semestriel du contrat de liquidité.
Transaction in Own Shares
2025-01-21 French
Affluent Medical : Nombre d’actions composant le capital social et nombre total de droits de vote au 31.12.24.
Declaration of Voting Results & Voting Rights Announcements
2025-01-08 French